CM Hospitalar SA

As of June 30, 2026, CM Hospitalar SA carries a market capitalization of 230.64M, placing it among publicly traded companies globally. Its enterprise value stands at 3.60B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

CM Hospitalar SA's next confirmed earnings release is scheduled for November 10, 2026.

As of June 30, 2026, CM Hospitalar SA has 315.94M shares outstanding.

As of June 30, 2026, CM Hospitalar SA trades at a trailing price-to-earnings ratio of 4.05. The price-to-sales ratio is 0.02, and the price-to-book ratio stands at 0.13.

As of June 30, 2026, CM Hospitalar SA trades at an EV/EBITDA multiple of 3.72 - the valuation measure that neutralizes differences in capital structure, tax rates, and depreciation policy, making it the standard yardstick for comparing companies across an industry. The EV/Sales ratio of 0.31 reflects the premium investors pay for the company's revenue stream, a useful check when earnings are depressed or negative. Its EV/EBIT multiple of 5.82 values the business against core operating earnings after depreciation, a stricter test than EV/EBITDA for capital-intensive businesses. These enterprise value multiples are built on an enterprise value of 3.60B versus a market cap of 230.64M, with the gap driven by net debt and cash on the balance sheet.

As of June 30, 2026, CM Hospitalar SA maintains a current ratio of 1.72, meaning it holds 1.7x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 209.74, indicating elevated leverage, while an interest coverage ratio of 1.32 demonstrates limited ability to service its debt obligations.

Over the twelve months ended June 30, 2026, CM Hospitalar SA posted a return on equity (ROE) of 3.15, showing how much profit the company earns on every dollar of shareholder capital. Return on assets (ROA) stands at 0.63, measuring how efficiently the asset base is converted into earnings. The company generates approximately 1.95M in revenue per employee across its workforce of 6,000.00, a quick read on workforce productivity versus industry peers. Inventory turnover of 5.70 indicates how many times CM Hospitalar SA sells and replaces its inventory over a year, a key working capital efficiency ratio.

Over the twelve months ended June 30, 2026, CM Hospitalar SA recorded an income tax benefit of -17.07M rather than an expense, typically from losses, carryforwards, or the release of a tax provision. Taxes are levied on pretax income of 39.80M, leaving 56.87M in net income after tax - the gap is what shifts in the tax rate do to reported earnings and EPS.

As of the close on October 22, 2026, CM Hospitalar SA's stock has declined approximately 15.97% over the past 52 weeks. The 50-day moving average sits at 0.81, while the 200-day moving average is 1.12.

Over the twelve months ended June 30, 2026, CM Hospitalar SA generated 11.71B in revenue and converted that into 56.87M in net income, yielding earnings per share of 0.18. EBITDA reached 969.13M, while operating income came in at 640.69M.

As of June 30, 2026, CM Hospitalar SA holds 450.96M in cash and equivalents against 3.82B in total debt, resulting in a net debt position of 2.98B. Total book value stands at 1.82B, with working capital of 1.88B providing operational flexibility.

CM Hospitalar SA produced 269.10M in operating cash flow over the twelve months ended June 30, 2026. After subtracting -115.47M in capital expenditures, free cash flow totaled 153.63M - equivalent to 0.49 per share.

Over the twelve months ended June 30, 2026, CM Hospitalar SA posted a gross margin of 15.31, reflecting its pricing power and cost economics. The operating margin of 5.47 and net profit margin of 0.49 provide insight into operational efficiency.

These figures cover the twelve months ended June 30, 2026. Free cash flow yield stands at 66.64, showing how much cash the business generates relative to its market value - dividends covered by free cash flow are generally more durable than those funded by debt. Total shareholder yield reaches 207.71, combining dividends paid with share buybacks and debt reduction for a fuller picture of capital returned to CM Hospitalar SA shareholders.

As of June 30, 2026, CM Hospitalar SA has an Altman Z-Score of 2.49, near the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.